Inari Medical Inc Receives Positive Ratings from Guru Model

Inari Medical Inc (NARI) shines with a 66% rating from a prominent growth model. Investors may see positive signals despite some weaknesses in sales and expenditures.

Date: 10-02-2025

AI Rating: 5

Analysis of Inari Medical Inc

The report on Inari Medical Inc (NARI) highlights the stock's rating of 66% based on the P/B Growth Investor model created by Partha Mohanram. This rating indicates a strong consideration for future growth, particularly as it highlights the company's low book-to-market ratio, which is crucial for growth-oriented investors.

The report shows several key fundamentals that are performing well:

Book/Market Ratio: Pass
Return on Assets: Pass
Cash Flow from Operations to Assets: Pass
Cash Flow from Operations to Assets vs. Return on Assets: Pass
Return on Assets Variance: Pass
Research and Development to Assets: Pass

These positive indicators suggest that Inari Medical is efficiently utilizing its assets to generate profits, which may be attractive to investors looking for solid performance in the medical equipment sector.

However, there are notable weaknesses as well:

Sales Variance: Fail
Advertising to Assets: Fail
Capital Expenditures to Assets: Fail

These areas of concern, particularly regarding sales variance and capital expenditures, may deter some investors. The failures in these areas could indicate challenges the company faces in maintaining revenue growth, which is often critical for sustaining higher stock prices.

Overall, while the stock has positive ratings in many critical areas and showcases strong fundamentals, the noted weaknesses could influence investor sentiment negatively, potentially impacting NARI’s stock prices.

Stocks: NARI